ADBiotech Co

ADBiotech Co Capital Expenditures

The Capital Expenditures (CapEx) of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is -377.68 M KRW. In the previous year, Capital Expenditures (CapEx) was -193.38 M KRW — a change of 95.30% (lower).

Capital Expenditures

-377.68 MKRW

YoY

95.30%

Last updated:

Capital Expenditures (CapEx) of ADBiotech Co is 2025 -377.68 M KRW. Capital Expenditures (CapEx) of ADBiotech Co was 2024 -193.38 M KRW. It decreases by 95.30% lower compared to the previous year.

The ADBiotech Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-2.39 B KRW
Jan 1, 2019
-94.47 M KRW
Jan 1, 2020
-5.29 B KRW
Jan 1, 2021
-3.56 B KRW
Jan 1, 2022
-726.72 M KRW
Jan 1, 2023
-289.90 M KRW
Jan 1, 2024
-193.38 M KRW
Jan 1, 2025
-377.68 M KRW
The ADBiotech Co Capital Expenditures history
YEARCapital ExpendituresYoY
-377.68 MKRW+95.30%
-193.38 MKRW-33.29%
-289.90 MKRW-60.11%
-726.72 MKRW-79.59%
-3.56 BKRW-32.67%
-5.29 BKRW+5,498.82%
-94.47 MKRW-96.05%
-2.39 BKRW+4.53%
-2.29 BKRW+344.21%
-514.94 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Capital Expenditures (CapEx) of ADBiotech Co is -377.68 M KRW in 2025.

Capital Expenditures (CapEx) of ADBiotech Co changed from -193.38 M KRW to -377.68 M KRW, representing a 95.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ADBiotech Co

All Key Metrics — ADBiotech Co